Related Experiment Video
Updated: Jul 15, 2026

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
Published on: June 28, 2021
Acute pancreatitis associated with ifosfamide
Miao-Chiu Hung1, Giun-Yi Hung, Pei-Chin Lin
1Department of Pediatrics, Taipei Veterans General Hospital, and National Yang-Ming University School of Medicine, Taipei, Taiwan, R.O.C.
Abstract:
Acute pancreatitis is a rare complication during chemotherapy for pediatric patients with solid tumors. We report a 9-year-old boy with osteosarcoma who experienced 2 episodes of pancreatitis 1 day and 48 days after infusion of ifosfamide (IFOS), respectively. From a MEDLINE search, this is the 3rd reported case and 2nd reported pediatric case of IFOS-induced pancreatitis, and only this case experienced late-onset pancreatitis.
Insights
Acute pancreatitis is a rare chemotherapy complication. This case highlights late-onset pancreatitis in a child treated with ifosfamide (IFOS), a chemotherapy drug, after osteosarcoma treatment.
Area of Science:
- Oncology
- Pediatric Oncology
- Gastroenterology
Background:
- Acute pancreatitis is an uncommon but serious adverse event during chemotherapy for pediatric solid tumors.
- Ifosfamide (IFOS) is an alkylating agent used in treating various pediatric cancers, including osteosarcoma.
Observation:
- A 9-year-old boy diagnosed with osteosarcoma developed two distinct episodes of acute pancreatitis.
- The first episode occurred one day post-ifosfamide infusion, and the second episode manifested 48 days after treatment.
Findings:
- This report represents the third documented case of ifosfamide-induced pancreatitis and the second pediatric case.
- Notably, this is the first reported instance of late-onset pancreatitis associated with ifosfamide treatment.
Implications:
- The findings suggest a potential for delayed pancreatic toxicity from ifosfamide in pediatric oncology patients.
- Clinicians should maintain a high index of suspicion for pancreatitis, including late-onset presentations, in children receiving ifosfamide.
- Further investigation into the mechanisms and risk factors for ifosfamide-induced pancreatitis is warranted.
More Related Videos
07:38Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
Published on: May 10, 2024
07:10Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
Published on: April 1, 2022
Related Concept Videos
Acute Pancreatitis I: Introduction
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Pancreatitis II: Pathophysiology
Chronic Pancreatitis I: Introduction
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...